Marie-Emilie Dourthe

I am working in the pediatric immuno-hematology department in Robert Debré University Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Université de Paris Cité, in Paris (France). I have wards responsibilities and faculty tasks.

I am particularly implicated in managing patients with B-cell acute lymphoblastic leukemia treated with CAR T-cells (in commercial use or clinical trials). I have reported on the French experience of CAR T-cells targeting CD19 antigen in children, adolescents and young adults  patients with B-cell acute lymphoblastic leukemia in collaboration with Saint Louis Hospital (Paris, France).

I am co-investigator of the phase I/II protocol sponsored by APHP: CAPTiRALL, Combination of an Anti-PD1 antibody with Tisagenlecleucel Reinfusion in children, adolescents and young adults with Acute Lymphoblastic Leukemia after loss of persistence.